ZBH vs PODD — Key Metrics

Metric ZBH (ZIMMER BIOMET HOLDINGS INC) PODD (INSULET CORP)
Price103.32139.98
Market Cap19.55 Billion9.71 Billion
P/E (TTM)26.0322.8
P/B (Quarterly)1.6397.249
P/S (TTM)2.283.04
Net Profit Margin (TTM)9.013.4
Gross Margin (TTM)69.771.9
ROE (TTM)6.129.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

ZIMMER BIOMET HOLDINGS INC
vs
 
INSULET CORP
 
ZIMMER BIOMET HOLDINGS INC
vs
 
INSULET CORP
Performance Comparison
AI Model Recommendation
ZBH · ZIMMER BIOMET HOLDINGS INC

Underperform

-16
UnderperformOutperform
PODD · INSULET CORP

Outperform

47
UnderperformOutperform
Recommendation Summary

Stock ZBH is projected to underperform the market, stock PODD is projected to outperform the market. Upfront Recommendation: PODD.

Financial Metrics
Prices delayed ~15 min
ZBH Metrics PODD
$103.32 Price $139.98
— Market Capitalization —
26.03 Price to Earnings Ratio 22.8
2.28 Price to Sales 3.04
15.1 Price to FCF Ratio 41.75
3.27 Price to Gross Profit 4.24
45.18 Price to R&D 26.95
3.81 Price to Current Assets 4.76

ZBH vs PODD at a glance

Zimmer Biomet Holdings INC (ZBH) and Insulet Corp (PODD) are both Medical Devices companies in the Healthcare sector. ZBH is the larger, at $19.6 billion in market value against $9.7 billion for PODD, about 2.0 times the size.

On trailing-twelve-month figures, ZBH trades at 26.0 times trailing earnings and PODD at 22.8; net profit margins are 9.0% and 13.4%.

The Upfront Investment model currently rates ZBH Underperform and PODD Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.